The company said March 26 that the funding will allow it to produce 150 million vials this year, a 50 percent increase from its previous estimates, according to The Wall Street Journal. The 150 million vials can hold about 1.2 billion vaccine doses.
Corning plans to use the funding to hire more manufacturing workers, upgrade its glassmaking machinery and accelerate the opening of a plant in Durham, N.C., the Journal reported. The company also plans to expand its plants in Vineland, N.J., and Big Flats, N.Y.
Corning’s vials use a new type of glass, called Valor glass, which is designed to be stronger and less likely to crack, according to the Journal. The glass can withstand the subzero temperatures some COVID-19 vaccines require.
Read the full article here.
More articles on supply chain:
US pulls 25M isolation gowns from national stockpile over safety concerns
Carcinogen found in 44 hand sanitizer brands introduced during pandemic
How Cardinal Health is using tracking technology to get a better look into its supply chain
